Recursion Pharmaceuticals In
RXRX
$5.36-0.05 (-0.92%)
Aug 8, 2025, 4:00 PM
Financials
| 52Week High | 12.36 | 52Week Low | 3.79 |
| Beta | 0.95 | Current Ratio Annual | 3.81 |
| Current Ratio Quarterly | 3.58 | Gross Margin TTM | -3.51 |
| Market Cap | 2.33B | Net Profit Margin TTM | -1,004.91 |
| Operating Margin TTM | -1,020.83 | Price To Book | 2.53 |
| Price To Sales TTM | 36.02 | Quick Ratio Annual | 3.81 |
| Quick Ratio Quarterly | 3.58 | Return On Assets TTM | -54.29 |
| Return On Equity TTM | -76.09 | Return On Investment TTM | -73.84 |
| Revenue Growth3Y | 79.46 | Revenue Growth5Y | 90.91 |
| Revenue Growth Quarterly Yoy | 33.34 | Revenue Growth TTMYoy | 30.15 |
| Revenue Per Share TTM | 0.15 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 334 | 66 | 46 | 135 | 70 | 59 | 310.61M | $1.63B |
| Jun 30, 2025 | 142 | 24 | 30 | 43 | 33 | 35 | 81.09M | $407.34M |
| Change | 192(57%) | 42(64%) | 16(35%) | 92(68%) | 37(53%) | 24(41%) | 229.53M(74%) | $1.22B(75%) |